the Industry

A-one-hour workshop presented by experts actively involved in the field of laboratory medicine, providing a broad and in-depth overview of a selected relevant topic in the field, sharing the most recent cutting edge research discoveries and technologies.

Establishing High Quality Standards Through Lab Accreditation

Supported by Al Borg Medical Laboratories

Friday, November 1, 12:00 – 12:45 in Lecture Hall 5
Speaker: Ahmed Awad, MD, P.hD., Assistant Professor of Chemical Pathology, Alexandria University, Egypt and Lab Director, Al Borg Medical Laboratories, Abu Dhabi, UAE

During this workshop, different quality definitions and the concept of accreditation will be discussed, with their impact on laboratory performance. After attending this workshop you will learn the whole accreditation process from application till the final accreditation, and how to overcome challenges and maintain accreditation at your laboratory from different accrediting bodies. Different accrediting bodies and standards (CAP, ISO 15 189, JCI and CBAHI) will be tackled.

1. Clinical Validation of Snibe MAGLUMI 800 free testosterone assay

Supported by Snibe Diagnostic

Friday, November 1, 12:00 – 12:45 in Lecture Hall 4
Speaker: Dr Waleed Tamimi, Member of Executive Board of Saudi Society for Clinical Chemistry (SSCC), Consultant and Head of Clinical Chemistry Section at King Abdulaziz Medical City, National Guard, Riyadh, Saudi Arabia

Most circulating testosterone is tightly bound to sex hormone-binding globulin (SHBG) or weakly bound to albumin. The concentration of free testosterone is about <2% of the total testosterone concentration. The free and albumin-bound forms comprise about 35% of total testosterone and are believed to be the biologically active part.

There are many available assays to measure total testosterone, the commonest one is the direct chemiluminescent, however, suffer from limitations such as lack of specificity for cross-reacting steroids, insufficient analytical sensitivity, and imprecision at low concentrations. Routinely available assay methods used to measure total testosterone are not sensitive enough to accurately quantitate the free testosterone fraction directly. Again direct chemiluminescent immunoassay methods are the easiest and fastest available methods of assessing free testosterone. Whether total testosterone or free testosterone measurements most closely correlate with symptomatic androgen deficiency is still a matter of debate.

In this presentation, we will share our local evaluation of the Snibe MAGLUMI 800 free testosterone assay. In Addition, we will discuss some clinical cases of validating free testosterone using different manufacturer’s immunoassays.

2. Test Performance on a Snibe Platform in a CAP/ISO15189 Accredited Laboratory

Supported by Snibe Diagnostic

Friday, November 1, 12:00 – 12:45 in Lecture Hall 5
Speaker: Dr. George Sahyoun, Chief Scientific Officer & Director, Medlabs Reference Lab, Amman, Jordan

As one of the main reference laboratories within the MENA region, MedLabs had always strived to provide the largest menu of test possible while maintaining the highest quality standards to ensure reliable and reproducible results for our end users.

As a CAP/ISO15189 accredited lab, only the most robust and reliable platforms are added into service within our lab. The Snibe Maglumi 4000 has proven to meet all these requirements and more. It has played a major role especially in allowing us to introduce rarer tests on a high throughput platform which would not normally be offered by other competing manufacturers.

This presentation will focus on the performance of Maglumi 4000 as a platform as well as the specific performance of certain analytes such as Androstenedione and NT-proBNP.

Clinical Decision Support on a Healthcare e-Platform

Supported by Abbott Diagnostics

Saturday, November 2, 12:00 – 12:45 in Lecture Hall 5
Speaker: Mr. Umar Ansari, Professional Services Executive & CSO, Abbott Diagnostics Africa, Middle East, & SW Asia

We invite attendees in this presentation on a journey of insight, understanding performance of today and generate together collaborative opportunities to achieving operational and integrated clinical care excellence for healthcare using clinical decision support systems. The goal is to understand performance of today and identifying the competencies required and supporting technologies to reach the future performance status to deliver measurably better healthcare in alignment with the international healthcare strategic outset.

Where Care Leads

Supported by Roche Diagnostics

Saturday, November 2, 12:00 – 12:45 in Lecture Hall 4
1. Driving the Business of Care
Speaker: Mr. Alaa Salama, Senior Group Product Manager, Middle East, Centralized Solutions, Roche Diagnostics Middle East FZCO

The talk addressing the lab to discover, "how the right partnership can help, and drive the organization forward".

Roche is going beyond product supplier to a strategic partner in 3 ways:

1. Through Roche Healthcare consulting tools & methodologies that support in driving profitability to the Lab.
2. With technological and medical innovation for patient access that increases Lab capabilities.
3. By digitalizing diagnostics to enhance effective and efficient outcomes for the Lab.

2. Operational Effectiveness
Speaker: Mr. Anis Yamani, Product Manager, Middle East, Centralized Solutions, Roche Diagnostics Middle East FZCO

Today laboratories are facing tremendous challenges. i.e. to reduce their budget, increasing in volumes with pressure to process results in shorter TATs, control over the processes, and keeping a high level of quality as well. To answer all these challenges Roche is the choice of partner to make this journey together.

The 2019

Delivering the latest scientific advances in all disciplines pertinent to the field of laboratory medicine. Leaders in laboratory science and management from countries throughout the region including Bahrain, Kuwait, Qatar, Saudi Arabia, United Arab Emirates, Oman, Jordan, Egypt, Turkey, Lebanon, Cyprus, and the entire African continent will be invited to participate. Attendees will include laboratory directors and managers, government officials, and representatives of the diagnostics industry.

AACC Middle East will feature AACC’s globally-renowned education and scientific programs paired with a dynamic exposition and will showcase the latest developments in clinical laboratory medicine, innovations from the in vitro diagnostics industry, and best practices from experts in the field.

This 2-day conference will include emerging topics relevant to the Middle East, while the exposition will highlight the latest advances in mobile health, molecular diagnostics, mass spectrometry, next-generation sequencing, point-of-care, and automation.